CPI-613 in Treating Patients With Advanced or Metastatic Bile Duct Cancer That Cannot Be Removed By Surgery
Status:
Completed
Trial end date:
2018-05-18
Target enrollment:
Participant gender:
Summary
This pilot clinical trial studies 6,8-bis(benzylthio)octanoic acid in treating patients with
advanced or metastatic cholangiocarcinoma that cannot be removed by surgery.
6,8-Bis(benzylthio)octanoic acid may stop the growth of cholangiocarcinoma by blocking blood
flow to the tumor